Position in SRPT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$49,808,490
+$6,532,290 QoQ
Shares Held
2,771,758
+39.4% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. SRPT ranks #83 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,808,490 | 2,771,758 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $43,276,200 | 1,988,796 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $40,981,073 | 1,904,325 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $33,166,059 | 1,721,124 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $32,079,547 | 1,875,997 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $116,211,177 | 1,820,921 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $207,475,460 | 1,706,353 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $211,857,650 | 1,696,354 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $261,023,584 | 1,652,048 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $196,827,100 | 1,520,370 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $141,707,452 | 1,469,537 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $170,771,705 | 1,408,775 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $158,963,265 | 1,388,083 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $173,937,462 | 1,261,971 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $157,923,292 | 1,218,732 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $127,596,100 | 1,154,298 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $85,408,149 | 1,139,383 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $89,734,100 | 1,148,670 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $101,941,642 | 1,132,056 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $91,088,453 | 984,953 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $76,518,549 | 984,288 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $72,276,436 | 969,763 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $160,070,162 | 938,883 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $124,502,569 | 886,581 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $143,203,822 | 893,126 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $83,225,842 | 850,806 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||